Sanofi-Aventis
Sanofi buys into cancer antibody research
January 26, 2011Research and Development Cancer, Oxford Biotherapeutics, Sanofi, Sanofi-Aventis, antibody drug conjugate, cancer research
Sanofi-Aventis has bought a global licence to develop and commercialise one of Oxford BioTherapeutics’ (OBT) oncology programmes. For an undisclosed …
Genzyme plans new Belgium facility
January 25, 2011Manufacturing and Production Belgium, Genzyme, Lumizyme, Myozyme, Pompe disease, Sanofi-Aventis, alglucosidase alfa
US rare disease drug specialist Genzyme, the subject of a hostile takeover offer from France’s Sanofi-Aventis, says that it will …
Boehringer’s Pradaxa advertising breaches Code
January 21, 2011Medical Communications ABPI, Bayer Schering Pharma, Boehringer Ingelheim, Code of Practice, PMCPA, Sanofi-Aventis
Boehringer Ingelheim has fallen foul of the ABPI Code of Practice on five counts in a row over an advertisement …
Sanofi ‘considering’ raising Genzyme offer
January 19, 2011Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, pharma mergers and acquisitions
Sanofi-Aventis could be willing to raise its offer to $76 a share to buy the US biotech firm Genzyme, according …
BMS and Sanofi recall 64 million Avalide tablets
January 18, 2011Manufacturing and Production Avalide, Avapro, Bristol-Myers Squibb, GMP, Good Manufacturing Practice, Sanofi-Aventis, hypertension, irbesartan
Bristol-Myers Squibb and Sanofi-Aventis have started another massive recall of their antihypertensive product Avalide because a manufacturing defect could affect …
Digital Pharma: Sanofi launches diabetes blog
January 17, 2011Medical Communications, Sales and Marketing Digital Pharma blog, Sanofi-Aventis, blog, diabetes
Sanofi-Aventis has ramped up its social media efforts with the launch of a blog about diabetes for US consumers. The …
Digital Pharma: NHS thrombosis e-learning
January 14, 2011Medical Communications Bayer, Boehringer Ingelheim, Digital Pharma blog, NHS training, Pfizer, Sanofi-Aventis, VTE, e-learning, venous thromboembolism
The NHS has launched a best-practice website to help educate healthcare professionals about one of the most common causes of …
Sanofi boosts emerging markets leadership team
January 11, 2011Sales and Marketing Brazil, China, Heraldo Marchezini, Japan, Jeremy Moulding Russia, Patrick Aghanian, Sanofi-Aventis, Thomas Kelly, appointments, emerging markets, sales and marketing
Sanofi-Aventis has bolstered its emerging markets team with the appointment of four senior managers. They are Patrick Aghanian, Thomas Kelly, …
Sanofi’s Genzyme takeover bid focuses on Campath
January 10, 2011Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, biotech acquisition
Sanofi-Aventis and Genzyme have come back to the negotiation table to discuss the potential of Genzyme’s multiple sclerosis drug Campath. …
Sanofi workers strike in France
January 7, 2011Research and Development, Sales and Marketing Sanofi, Sanofi-Aventis, strikes, unions
Sanofi-Aventis workers have gone on strike in France as the company looks to cut jobs. Nine unions representing workers at …
Digital Pharma: First big pharma Android apps launched
January 4, 2011Medical Communications Android, Digital Pharma blog, Novartis, Sanofi-Aventis, apps, ipad, iphone
Big pharma’s smartphone marketing is starting to look beyond Apple’s attention-grabbing iPhone as companies produce the first apps for its …
Sanofi signs new oncology research deals
December 20, 2010Research and Development Avila Therapeutics, Cancer, INDOX, India, Oxford University, Sanofi, Sanofi-Aventis, cancer research, covalent drugs
Sanofi-Aventis has signed two new cancer research deals, including one that will see it partner with Avila Therapeutics to discover …
Sanofi and Merck Serono to collaborate in oncology
December 17, 2010Research and Development Cancer, MSC1936369B, Merck Serono, SAR245408, SAR245409, Sanofi, Sanofi-Aventis
Sanofi-Aventis and Merck Serono are to join forces to study three new cancer drug candidates. The collaboration will see the companies …
Sanofi-Aventis appoints Dr Elias Zerhouni head of R&D
December 15, 2010Research and Development Dr Elias Zerhouni, Sanofi-Aventis, appointment, research and development
Dr Elias Zerhouni has been appointed president of global research and development at Sanofi-Aventis with effect from 1 January 2011. …
Sanofi extends Genzyme share deal deadline
December 14, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, mergers and acquisitions, pharma acquisitions
Sanofi-Aventis has extended the deadline to acquire Genzyme after the US biotech’s shareholders have so far proved immune to its …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
